ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
April 2026
Latest News
NRC approves TerraPower construction permit
Today, the Nuclear Regulatory Commission announced that it has approved TerraPower’s construction permit application for Kemmerer Unit 1, the company’s first deployment of Natrium, its flagship sodium fast reactor.
This approval is a significant milestone on three fronts. For TerraPower, it represents another step forward in demonstrating its technology. For the Department of Energy, it reflects progress (despite delays) for the Advanced Reactor Demonstration Program (ARDP). For the NRC, it is the first approval granted to a commercial reactor in nearly a decade—and the first approval of a commercial non–light water reactor in more than 40 years.
John N. Hamawi
Nuclear Technology | Volume 195 | Number 3 | September 2016 | Pages 363-370
Technical Note | doi.org/10.13182/NT16-18
Articles are hosted by Taylor and Francis Online.
Estimates of radiation doses to receptors in the vicinity of nuclear power plants from gaseous effluents are important to ensure that plant operation is in compliance with the as-low-as-reasonably-achievable dose objectives delineated in 10 CFR 50, Appendix I. The U.S. Nuclear Regulatory Commission (NRC) recently issued an Advance Notice of Proposed Rulemaking (ANPR) on the development of a new regulatory basis in support of aligning the NRC regulations governing dose assessments for radioactive effluents with the most recent methodology published by the International Commission on Radiological Protection (ICRP) contained in ICRP Publication 103 (ICRP-103) (2007). The ANPR specifically recommends that the dose conversion factors (DCFs) in Regulatory Guide 1.109 (RG 1.109) be revised as part of any effort to more closely align the NRC’s regulations with the ICRP-103 recommendations. Section C.2 of RG 1.109 provides a sector-average (SA) finite-cloud model for computation of annual doses at off-site receptors from noble gas releases from freestanding tall stacks. One of the limitations of this model is that embedded in the applicable equation is the DCF, and as such, the model is not suitable for implementation of the ANPR (if approved) and the recommended use of stand-alone updated DCFs. This limitation can be circumvented through use of the “gamma atmospheric dispersion factor” in the finite-cloud dose model, referred to as the gamma (χ/Q). A second limitation of the SA finite-cloud model is the dose overestimation at close-in receptors under very stable conditions and elevated plumes, which can be eliminated by using the corresponding finite-cloud gamma (χ/Q) for the plume-centerline (PC) model. Presented are analytical details on the derivation and use of the SA and PC gamma (χ/Q)’s, which are suitable for incorporation of stand-alone updated sets of DCFs based on ICRP-103.